Researchers reported results where they tested performance on a theoretically-based probabilistic decision-making video simulation in adults with and without attention-deficit/hyperactivity disorder (ADHD). The study examined the relationship between experimental risk taking and history of real-life, risk-taking substance use behavior. Both groups showed similar patterns of risk taking, but adults with ADHD had more history and use of substance use and abuse.
The link between attention-deficit/hyperactivity disorder (ADHD) and risk-taking behavior, including substance abuse, is a major public health issue. Studies estimate 30% of adults presenting with substance use disorder (SUD) have ADHD, and approximately 20% to 40% of adults with ADHD have histories of SUD.
In a recent study published in Psychiatry Research, researchers tested performance on a theoretically-based probabilistic decision-making video simulation in adults with and without ADHD. The study examined the relationship between experimental risk taking and history of real-life risk-taking behavior, defined as cigarette, alcohol, and street drug use.
University students with and without ADHD (n = 62, with 31 in each group), completed a modified version of the Cambridge Gambling Test (CGT), in which they had to choose between alternatives varied by level of risk. They also reported their history of substance use. Those who were on prescription medication for ADHD were asked not to take the medicine for 24 hours before the tests.
Both groups showed similar patterns of risk taking on the experimental decision-making task, suggesting that ADHD is not linked to low sensitivity to risk. Past and present substance use was more prevalent in adults with ADHD.
The researchers wrote that their finding questions the validity of the simulation as a valid model for ADHD-related risk-taking behavior.
The CGT or other risk-taking simulators have become more widely used in recent years as a way to provide a model of actual risk-taking behavior while controlling for key variables. The CGT uses pricing tasks, where participants are asked how much money (points) they wish to invest for the chance to gamble. Subjects are given explicit probabilistic information (eg, 20% chance that a token was hidden inside a blue box, 80% chance it was hidden inside a red box). The subjects are then asked to guess in which box the token is placed, and to determine the magnitude of bet they are willing to risk, given the probabilities.
The CGT separately taps several processes that are involved in decision making:
In this study, no significant differences between groups were observed regarding sum of bet, risk adjustment, and deliberation time. Adults with ADHD did not choose the riskier options more often than controls. These findings suggest that other characteristics of the task, such as the need to wait before choosing an option, account for previous findings showing greater risk taking by participants with ADHD on similar tasks.
Reference
Pollaka T, Shalita R, Aranb A. Risk taking and adult attention deficit/hyperactivity disorder: A gap between real life behavior and experimental decision making. Psychiatry Res. 2018; (259):56—62. dx.doi.org/10.1016/j.psychres.2017.10.012
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More